Fresenius Kabi

Fresenius Kabi

Arzneimittelherstellung

Bad Homburg, Hessen 394.768 Follower:innen

With our passion and expertise, we touch the lives of almost 450 million people every year.

Info

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com. Imprint: www.fresenius-kabi.com/imprint

Branche
Arzneimittelherstellung
Größe
10.001+ Beschäftigte
Hauptsitz
Bad Homburg, Hessen
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Spezialgebiete
I.V. Generic Drugs, Infusion Therapies, Clinical Nutrition (enteral and parenteral), Medical Devices, Transfusion Technology Products, Biosimilars und Biopharmaceuticals

Orte

Beschäftigte von Fresenius Kabi

Updates

  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    Ready to see sustainability in action? Check out our interactive graphic in the Sustainability Highlights Report to learn how we act today for a better tomorrow. 🌍 Click through to explore how sustainability marks the manufacturing process at Fresenius Kabi 🏭, and discover more about sustainability targets and measures in our Sustainability Hub, such as 🟢 energy and climate, 🟢 water and waste water, 🟢 product development, or 🟢 automation and digitalization. 🔍 Explore our graphic here: https://lnkd.in/ene-A38x #SustainableManufacturing #Sustainability #FutureFresenius #CommittedToLife

  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    Stay up-to-date about our company’s strategic progress and financial updates on the Fresenius Investor Relations channel. What to expect? 🌍 Insights from investor conferences and roadshows 📊 Strategic and financial updates on #FutureFresenius 💡 In-depth trends in investor relations At Fresenius, we work as One Team and collaborating across departments is key for us to drive success and reinforce our company’s promise #CommittedToLife. Join us by following Fresenius Investor Relations for more insights! #TeamFresenius

  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    As we close the chapter on 2024, we celebrate the milestones that we achieved on our journey towards Vision 2026, contributing to #FutureFresenius. This year’s achievements reflect the power of collaboration, innovation, and dedication – driven by our incredible colleagues worldwide. Together, as One Team, we have made an impact worth celebrating. Join us in looking back at a selection of the key moments that defined 2024 and set the stage for a successful year to come. Wishing you a happy New Year filled with health and happiness! 🎉 #CommittedToLife

  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    We are pleased to announce that Fresenius Kabi has entered into a licensing agreement with SamChunDang Pharm (SCD) of South Korea to commercialize a proposed aflibercept biosimilar in the US and several Latin American countries. This marks another important milestone supporting #FutureFresenius, broadening our growing biopharma portfolio and enhancing our capabilities to improve patient access to affordable therapies. #FreseniusKabi #Biosimilars #FutureFresenius #CommittedToLife 

    • Female scientist in the lab
  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    The holiday season is a time for giving. Many of us take this opportunity to give back – through donations or volunteering for causes that help others. 💝 One of the most meaningful ways to make a difference is by donating blood or plasma. Every blood donation can be a lifeline for someone in need. At Fresenius Kabi, blood donation is a cause close to our hearts. 🩸 Every year, our employees, along with their families and friends, come together to participate in numerous blood drives worldwide. This year alone, over 1,000 participants have joined our efforts, collecting hundreds of units of blood. Find a blood donation center near you and make this season truly special. 🌟 #SaveLives #BloodDonation #CommittedToLife

    • Our image features a smiling woman sitting in a donation chair, holding a blue sign that reads 'BLOOD DONOR. LIFE SAVER.' The text above says 'A season for gratitude and giving.'
  • Fresenius Kabi hat dies direkt geteilt

    Profil von Pierluigi Antonelli anzeigen, Grafik

    Fresenius Management SE Board Member - President and CEO of Fresenius Kabi

    As we reach the end of the year, I want to take this opportunity to reflect on what has been a truly remarkable year for Fresenius Kabi. It has been a year of growth, collaboration, and innovation – a testament to the incredible teams which drive our success every day – with significant impact on critically and chronically ill patients globally. As one team, we have consistently delivered on our commitments. The resilience and dedication of the Fresenius Kabi teams have made a decisive difference as we continued to progress along our #Vision2026 transformation. We are fully living our purpose of improving and saving human lives. We have taken major steps on that journey in line with #FutureFresenius: In 2024, we made significant progress in expanding our Biopharma business, delivering innovative therapies to support autoimmune and oncology patients worldwide. With multiple approvals from regulatory agencies and a growing pipeline of medicines under development, we are well-positioned to bring these critical treatments to market and improve access for patients globally. In MedTech, collaborations with leading companies in cell and gene therapy and our continued investment in cutting-edge manufacturing technologies have strengthened our ability to meet the needs of patients and health care providers worldwide. Fresenius Kabi also focuses on rolling out its Nutrition offering. We have seen various important launches in many markets throughout the year and we will continue to push this going forward. In Pharma, we have expanded our generics portfolio which ensures the supply of vital and affordable medicines to ever more people; and our IV Fluids are a true backbone of health care – clearly visible in our impressive efforts to assist in various shortage situations with our essential products. All of these milestones and achievements highlight one thing: as part of Fresenius, we are an essential provider of critical medicines and technologies. Our products are indispensable components of the global health care provision. And wherever we can, we will always assist in making care accessible to those in need. As we look to the coming year, our focus remains firmly on shaping future health care and improving patient outcomes. We will expand our leadership positions, strengthen our core competencies to better serve patients, and drive sustainability as well as innovation across all areas of our business. To all the teams, my dear colleagues, at Fresenius Kabi – thank you for your tireless dedication and for embodying our #CommittedToLife promise. Your passion and commitment inspire me daily, and I am deeply grateful to be part of this journey with you. Some of these colleagues share in the following video, what motivated them during 2024 – take a look! #FreseniusKabi

  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    Fresenius Kabi is expanding its pharmaceutical portfolio with the introduction of Epinephrine Injection, USP in 1 mg per mL single-dose vials. This essential medication supports critical patient care and reflects our commitment to providing high-quality medicines for healthcare professionals worldwide. Learn more: https://lnkd.in/ewsn2hfp #FreseniusKabi #FutureFresenius #CommittedToLife

    Unternehmensseite von Fresenius Kabi USA anzeigen, Grafik

    45.204 Follower:innen

    BREAKING: Fresenius Kabi is pleased to expand its Pharmaceutical portfolio with the introduction of  Epinephrine Injection, USP. Available in 1mg per mL single-dose vials, Fresenius Kabi Epinephrine Injection, USP is proudly formulated, filled, and packaged in the U.S. as part of the company's commitment to strengthening domestic production of essential medicines. “The introduction of Epinephrine Injection demonstrates Fresenius Kabi’s ongoing commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve,” said Arunesh Verma, president of Fresenius Kabi USA. Read the news release: https://lnkd.in/ewsn2hfp #MoreInAmerica #FutureFresenius #CommittedToLife

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Fresenius Kabi anzeigen, Grafik

    394.768 Follower:innen

    Ever wondered what goes on behind the scenes in our Mirandola plant in Italy? We sat down with Martino Balboni, our Technical Office Filter Manager, to dive into the exciting world of innovation, efficiency, and teamwork – all over his favorite Italian cappuccino, of course! ☕ Martino has been with Fresenius Kabi for eight years, and his journey is as impressive as it is inspiring. Starting as a process engineer and project manager, Martino helped launch the automation lines that now drive efficiency in our production. “When I first started, I spent months in the clean room, ensuring every detail of the automation was just right,” he shares. This hands-on experience laid the foundation for his expertise, allowing him to understand and optimize our processes at every level. Today, Martino manages a talented team dedicated to improving our production lines. “The thing I love most about my job is the variety,” he explains. "From Industry 4.0 advancements to safety improvements, every project challenges us to think differently. We’re not just maintaining our systems; we’re continuously enhancing them to increase efficiency and meet the highest standards of quality and safety.” 🤝 When asked what makes working at Fresenius Kabi special, Martino doesn’t hesitate. “I’m proud to be part of a company where our work has a real impact. Some of my friends and even my brother work in hospitals, and they tell me how often they see our products there. It’s a reminder of our commitment to life – and to the people who rely on us every day.” Beyond the technical expertise, Martino values the trust and reliability that define his team’s approach. “For me, our commitment to life isn’t just about our products; it’s about keeping our promises, both to our clients and to each other,” he says. This philosophy drives his team, especially in moments where challenging projects and tight deadlines require everyone to work together seamlessly. And what does Martino do when he’s not in the clean room or office? “I’m a basketball fan and still play in a local league here in Mirandola,” he shares with a laugh. “It’s a great way to clear my head and stay active.” #TeamFresenius #CommittedToLife

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen